EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stimuli‐Responsive Hydrogel Microcapsules Harnessing the COVID‐19 Immune Response for Cancer Therapeutics

Amit Fischer iD, Avner Ehrlich iD, Yevgeni Plotkin iD, Yu Ouyang iD, Klil Asulin, Ioannidis Konstantinos, Chunhai Fan, Yaakov Nahmias, Itamar Willner iD

Angewandte Chemie International Edition · 23.10.2023 · 62 (43)

DOI: 10.1002/anie.202311590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 19.09.2023. Verfasst von Amit Fischer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, The Minerva Center for Bio-hybrid Complex Systems, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel. Hauptthemen laut MEDLINE: Green Fluorescent Proteins, COVID-19, Genetic Therapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of gene therapy and immunotherapy concepts, along recent advances in DNA nanotechnology, have the potential to provide important tools for cancer therapies. We present the development of stimuli‐responsive microcapsules, loaded with a viral immunogenetic agent, harnessing the immune response against the Coronavirus Disease 2019, COVID‐19, to selectively attack liver cancer cells (hepatoma) or recognize breast cancer or hepatoma, by expression of green fluorescence protein, GFP. The pH‐responsive microcapsules, modified with DNA‐tetrahedra nanostructures, increased hepatoma permeation by 50 %. Incorporation of a GFP‐encoding lentivirus vector inside the tumor‐targeting pH‐stimulated miRNA‐triggered and Alpha‐fetoprotein‐dictated microcapsules enables the demonstration of neoplasm selectivity, with approximately 5,000‐, 8,000‐ and 50,000‐fold more expression in the cancerous cells, respectively. The incorporation of the SARS‐CoV‐2 spike protein in the gene vector promotes specific recognition of the immune‐evading hepatoma by the COVID‐19‐analogous immune response, which leads to cytotoxic and inflammatory activity, mediated by serum components taken from vaccinated or recovered COVID‐19 patients, resulting in effective elimination of the hepatoma (>85 % yield).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Green Fluorescent ProteinsCOVID-19Genetic TherapyHumansHydrogen-Ion ConcentrationSARS-CoV-2Breast NeoplasmsCell Line, TumorHydrogelsCapsulesFemaleSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

Alpha-FetoproteinCancerDNA-TetrahedraImmunotherapyLentivirus

Substanzen

Green Fluorescent Proteinsspike protein, SARS-CoV-2HydrogelsCapsulesSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Institute of Chemistry, The Minerva Center for Bio-hybrid Complex Systems, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel.
  • Grass Center for Bioengineering, Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, 91904, Israel.
  • The Department of Anesthesiology, Critical Care and Pain Medicine, Hadassah University Hospital, Jerusalem, 9112001, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem Jerusalem, 9112001, (Israel).
  • School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules and National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.

ORCID-Profile: Amit Fischer, Avner Ehrlich, Yevgeni Plotkin, Yu Ouyang, Itamar Willner

Zitieren

APA

Fischer, A., Ehrlich, A., Plotkin, Y., Ouyang, Y., Asulin, K., Konstantinos, I., Fan, C., Nahmias, Y., & Willner, I. (2023). Stimuli‐Responsive Hydrogel Microcapsules Harnessing the COVID‐19 Immune Response for Cancer Therapeutics. Angewandte Chemie International Edition, 62(43). https://doi.org/10.1002/anie.202311590

Vancouver

Fischer A, Ehrlich A, Plotkin Y, Ouyang Y, Asulin K, Konstantinos I, et al. Stimuli‐Responsive Hydrogel Microcapsules Harnessing the COVID‐19 Immune Response for Cancer Therapeutics. Angewandte Chemie International Edition. 2023;62(43). doi:10.1002/anie.202311590

BibTeX
@article{Fischer2023,
  author = {Fischer, Amit and Ehrlich, Avner and Plotkin, Yevgeni and Ouyang, Yu and Asulin, Klil and Konstantinos, Ioannidis and Fan, Chunhai and Nahmias, Yaakov and Willner, Itamar},
  title = {Stimuli‐Responsive Hydrogel Microcapsules Harnessing the COVID‐19 Immune Response for Cancer Therapeutics},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  volume = {62},
  number = {43},
  doi = {10.1002/anie.202311590}
}
Kostenlos starten →